Anticipated Earnings for MediWound
MediWound, a company listed on the NASDAQ under the ticker MDWD, is set to disclose its quarterly earnings on November 21, 2023. Analysts have projected an earnings per share (EPS) of $-0.44 for the company. It is worth noting that while surpassing or falling short of earnings expectations can impact stock prices, the guidance provided for future performance can also significantly influence investor sentiment.
Past Earnings Performance
In the previous quarter, MediWound exceeded EPS projections by $0.51. Surprisingly, the stock price experienced a 1.54% decline the following day. To provide a comprehensive overview of the company’s historical performance, here are the earnings figures and corresponding price changes:
Quarter EPS Estimate EPS Actual Price Change %
Q2 2023 -0.41 0.10 -1.54%
Q1 2023 -0.30 -0.44 1.56%
Q4 2022 -0.59 -1.18 2.63%
Q3 2022 -0.56 -0.91 -10.78%
As of November 17, MediWound’s shares were trading at $8.33, representing a significant 22.68% decrease over the past 52 weeks. Given the negative returns, long-term shareholders may have concerns regarding the upcoming earnings announcement.
In summary, investors are eagerly awaiting MediWound’s earnings report, placing emphasis on both the EPS figures and the company’s guidance for future performance.
Updated on: 04/12/2023
Debt to equity ratio: Strong Buy
Price to earnings ratio: Strong Sell
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Strong Sell
8:00 PM (UTC)
Date:01 December, 2023
|Analyst / firm||Rating|
|Cowen & Co.||Buy|
MDWD Stock Analysis: Positive Growth in Earnings and Revenue, Despite Negative Net Profit Margin
On November 20, 2023, MDWD (MediWound Ltd.) stock opened at $8.50 and fluctuated between $8.50 and $8.85 throughout the day. The trading volume was 1,109 shares, significantly lower than the average volume over the past three months. MDWD has a market capitalization of $71.4 million and has shown positive growth in earnings and revenue this year. However, it has a negative net profit margin of -73.97%. The price-to-sales ratio is 2.54 and the price-to-book ratio is 5.61. On that day, MDWD stock increased by $0.05, resulting in a percentage change of +3.11%. Comparatively, SCYX and THTX also saw increases of $0.05, with percentage changes of +3.82% and +3.11% respectively. AFMD experienced a more significant increase of $0.07, resulting in a percentage change of +17.17%, while LOVF saw a decrease of $0.01, resulting in a percentage change of -1.03%. The next reporting date for MDWD is on November 21, 2023, with an anticipated earnings per share (EPS) of -$0.39 for the current quarter. MDWD reported annual revenue of $26.5 million and an annual profit of -$19.6 million for the previous year.
Mediwound Ltd (MDWD) Stock Shows Promising Future with Analysts Predicting Significant Increase in Target Price
On November 20, 2023, Mediwound Ltd (MDWD) stock performed well, with analysts predicting a promising future for the company. According to data from CNN Money, four analysts offered 12-month price forecasts for MDWD, with a median target of 25.50. The high estimate was 36.00, while the low estimate was 25.00. This median estimate represents a significant increase of 188.14% from the last recorded price of 8.85.
The consensus among the four polled investment analysts is to buy stock in Mediwound Ltd. This rating has remained steady since December, indicating a consistent belief in the company’s potential.
Examining the current quarter’s financials, Mediwound Ltd reported a loss of $0.39 per share. However, the company’s sales reached $5.0 million, suggesting a healthy revenue stream.
Investors should note that Mediwound Ltd is set to report its earnings for the current quarter on November 21, 2023. This upcoming report may provide further insights into the company’s financial performance and future prospects.
Based on the information provided, Mediwound Ltd appears to be an attractive investment opportunity. With the median target price forecasted to increase by 188.14% and a consensus “buy” rating from analysts, there is a positive sentiment surrounding MDWD stock. However, investors should conduct their own research and consider various factors before making any investment decisions.
It is essential to keep in mind that stock market performance can be volatile, and past performance is not always indicative of future results. Therefore, it is crucial to exercise caution and consult with a financial advisor or conduct thorough research before making any investment decisions.